Effect of intraoperative HES 6% 130/0.4 on the need for blood transfusion after major oncologic surgery: a propensity-matched analysis
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | ZAMPIERI, Fernando Godinho | |
dc.contributor.author | RANZANI, Otavio T. | |
dc.contributor.author | MORATO, Priscila Fernanda | |
dc.contributor.author | CAMPOS, Pedro Paulo | |
dc.contributor.author | CARUSO, Pedro | |
dc.date.accessioned | 2013-09-23T16:50:41Z | |
dc.date.available | 2013-09-23T16:50:41Z | |
dc.date.issued | 2013 | |
dc.description.abstract | OBJECTIVES: To evaluate the effect of the intraoperative use of hydroxyethyl starch on the need for blood products in the perioperative period of oncologic surgery. The secondary end-points included the need for other blood products, the clotting profile, the intensive care unit mortality and length of stay. METHODS: Retrospective observational analysis in a tertiary oncologic ICU in Brazil including 894 patients submitted to oncologic surgery for a two-year period from September 2007. Patients were grouped according to whether hydroxyethyl starch was used during surgery (hydroxyethyl starch and No-hydroxyethyl starch groups) and compared using a propensity score analysis. A total of 385 propensity-matched patients remained in the analysis (97 in the No-hydroxyethyl starch group and 288 in the hydroxyethyl starch group). RESULTS: A higher percentage of patients in the hydroxyethyl starch group required red blood cell transfusion during surgery (26% vs. 14%; p = 0.016) and in the first 24 hours after surgery (5% vs. 0%; p = 0.015) but not in the 24-to 48-hour period after the procedure. There was no difference regarding the transfusion of other blood products, intensive care unit mortality or length of stay. CONCLUSION: Hydroxyethyl starch use in the intraoperative period of major oncologic surgery is associated with an increase in red blood cell transfusions. There are no differences in the need for other blood products, intensive care unit length of stay or mortality. | |
dc.description.index | MEDLINE | |
dc.identifier.citation | CLINICS, v.68, n.4, p.501-509, 2013 | |
dc.identifier.doi | 10.6061/clinics/2013(04)11 | |
dc.identifier.issn | 1807-5932 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/2302 | |
dc.language.iso | eng | |
dc.publisher | HOSPITAL CLINICAS, UNIV SAO PAULO | |
dc.relation.ispartof | Clinics | |
dc.rights | openAccess | |
dc.rights.holder | Copyright HOSPITAL CLINICAS, UNIV SAO PAULO | |
dc.subject | Tetrastarch | |
dc.subject | Adverse Events | |
dc.subject | Blood Transfusion | |
dc.subject | Surgical Blood Loss | |
dc.subject | Surgery | |
dc.subject | Cancer | |
dc.subject.other | hydroxyethyl starch 130/0.4 | |
dc.subject.other | critically-ill patients | |
dc.subject.other | plasma-volume expansion | |
dc.subject.other | severe sepsis | |
dc.subject.other | orthopedic-surgery | |
dc.subject.other | cardiac response | |
dc.subject.other | cancer-patients | |
dc.subject.other | score methods | |
dc.subject.other | lung-cancer | |
dc.subject.other | resuscitation | |
dc.subject.wos | Medicine, General & Internal | |
dc.title | Effect of intraoperative HES 6% 130/0.4 on the need for blood transfusion after major oncologic surgery: a propensity-matched analysis | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.author.external | ZAMPIERI, Fernando Godinho:Hosp Canc AC Camargo, Intens Care Unit, Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, Emergency Med Discipline, Intens Care Unit, Sao Paulo, Brazil; Hosp Alemao Oswaldo Cruz, Intens Care Unit, Sao Paulo, Brazil | |
hcfmusp.author.external | MORATO, Priscila Fernanda:Hosp Canc AC Camargo, Intens Care Unit, Sao Paulo, Brazil | |
hcfmusp.author.external | CAMPOS, Pedro Paulo:Hosp Canc AC Camargo, Intens Care Unit, Sao Paulo, Brazil | |
hcfmusp.citation.scopus | 3 | |
hcfmusp.contributor.author-fmusphc | OTAVIO TAVARES RANZANI | |
hcfmusp.contributor.author-fmusphc | PEDRO CARUSO | |
hcfmusp.description.beginpage | 501 | |
hcfmusp.description.endpage | 509 | |
hcfmusp.description.issue | 4 | |
hcfmusp.description.volume | 68 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 23778341 | |
hcfmusp.origem.scielo | SCIELO:S1807-59322013000400501 | |
hcfmusp.origem.scopus | 2-s2.0-84878148635 | |
hcfmusp.origem.wos | WOS:000320002000011 | |
hcfmusp.publisher.city | SAO PAULO | |
hcfmusp.publisher.country | BRAZIL | |
hcfmusp.relation.reference | Abosaif NY, 2005, AM J KIDNEY DIS, V46, P1038, DOI 10.1053/j.ajkd.2005.08.033 | |
hcfmusp.relation.reference | Amar D, 2003, ANESTHESIOLOGY, V98, P337, DOI 10.1097/00000542-200302000-00011 | |
hcfmusp.relation.reference | Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786 | |
hcfmusp.relation.reference | Bellmann R, 2012, CLIN PHARMACOKINET, V51, P225, DOI 10.2165/11594700-000000000-00000 | |
hcfmusp.relation.reference | Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149 | |
hcfmusp.relation.reference | Brookhart MA, 2006, EPIDEMIOLOGY, V17, P373, DOI 10.1097/01.ede.0000222026.42077.ee | |
hcfmusp.relation.reference | Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716 | |
hcfmusp.relation.reference | Corcoran T, 2012, ANESTH ANALG, V114, P640, DOI 10.1213/ANE.0b013e318240d6eb | |
hcfmusp.relation.reference | D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B | |
hcfmusp.relation.reference | de Jonge E, 2001, CRIT CARE MED, V29, P1261, DOI 10.1097/00003246-200106000-00038 | |
hcfmusp.relation.reference | Doherty M, 2012, BRIT J ANAESTH, V109, P69, DOI 10.1093/bja/aes171 | |
hcfmusp.relation.reference | Drews RE, 2003, CLIN CHEST MED, V24, P607, DOI 10.1016/S0272-5231(03)00100-X | |
hcfmusp.relation.reference | Dubniks M, 2007, INTENS CARE MED, V33, P293, DOI 10.1007/s00134-006-0454-5 | |
hcfmusp.relation.reference | Franz A, 2001, ANESTH ANALG, V92, P1402 | |
hcfmusp.relation.reference | Gattas DJ, 2012, ANESTH ANALG, V114, P159, DOI 10.1213/ANE.0b013e318236b4d6 | |
hcfmusp.relation.reference | Gayat E, 2010, INTENS CARE MED, V36, P1993, DOI 10.1007/s00134-010-1991-5 | |
hcfmusp.relation.reference | Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358 | |
hcfmusp.relation.reference | Hahn RG, 2010, ANESTHESIOLOGY, V113, P470, DOI 10.1097/ALN.0b013e3181dcd88f | |
hcfmusp.relation.reference | Hartog CS, 2011, INTENS CARE MED, V37, P1725, DOI 10.1007/s00134-011-2385-z | |
hcfmusp.relation.reference | Hartog CS, 2011, ANESTH ANALG, V112, P635, DOI 10.1213/ANE.0b013e31820ad607 | |
hcfmusp.relation.reference | Hayden SJ, 2012, AM J RESP CRIT CARE, V185, P1049, DOI 10.1164/rccm.201110-1915CI | |
hcfmusp.relation.reference | James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229 | |
hcfmusp.relation.reference | Komatsu Y, 2012, WORLD J SURG, V36, P844, DOI 10.1007/s00268-012-1433-3 | |
hcfmusp.relation.reference | Kozek-Langenecker SA, 2005, ANESTHESIOLOGY, V103, P654, DOI 10.1097/00000542-200509000-00031 | |
hcfmusp.relation.reference | Kozek-Langenecker SA, 2008, ANESTH ANALG, V107, P382, DOI 10.1213/ane.0b013e31817e6eac | |
hcfmusp.relation.reference | Kvolik S, 2010, SURG ONCOL, V19, pE33, DOI 10.1016/j.suronc.2009.03.008 | |
hcfmusp.relation.reference | Langeron O, 2001, ANESTH ANALG, V92, P855 | |
hcfmusp.relation.reference | Lobo SM, 2011, CRIT CARE, V15, DOI 10.1186/cc10466 | |
hcfmusp.relation.reference | Miletin MS, 2002, INTENS CARE MED, V28, P917, DOI 10.1007/s00134-002-1337-z | |
hcfmusp.relation.reference | Ng T, 2012, J THORAC CARDIOV SUR, V143, P815, DOI 10.1016/j.jtcvs.2011.12.031 | |
hcfmusp.relation.reference | Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4 | |
hcfmusp.relation.reference | Perisanidis C, 2012, ORAL ONCOL, V48, P372, DOI 10.1016/j.oraloncology.2011.11.020 | |
hcfmusp.relation.reference | Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242 | |
hcfmusp.relation.reference | Persson J, 2006, CRIT CARE MED, V34, P2456, DOI 10.1097/01.CCM.0000233876.87978.AB | |
hcfmusp.relation.reference | Prowle JR, 2011, CRIT CARE, V15, DOI 10.1186/cc10318 | |
hcfmusp.relation.reference | Rzyman W, 2003, J THORAC CARDIOV SUR, V126, P755, DOI 10.1016/S0022-5223(03)00217-4 | |
hcfmusp.relation.reference | Schortgen F, 2004, INTENS CARE MED, V30, P2222, DOI 10.1007/s00134-004-2415-1 | |
hcfmusp.relation.reference | Schramko A, 2010, BRIT J ANAESTH, V104, P691, DOI 10.1093/bja/aeq084 | |
hcfmusp.relation.reference | Singer M, 2012, CURR OPIN ANESTHESIO, V25, P96, DOI 10.1097/ACO.0b013e32834e8150 | |
hcfmusp.relation.reference | Sossdorf M, 2009, CRIT CARE, V13, DOI 10.1186/cc8223 | |
hcfmusp.relation.reference | Trof RJ, 2010, INTENS CARE MED, V36, P697, DOI 10.1007/s00134-010-1776-x | |
hcfmusp.relation.reference | Verheij J, 2006, INTENS CARE MED, V32, P1030, DOI 10.1007/s00134-006-0195-5 | |
hcfmusp.relation.reference | Westphal M, 2009, ANESTHESIOLOGY, V111, P187, DOI 10.1097/ALN.0b013e3181a7ec82 | |
hcfmusp.scopus.lastupdate | 2024-05-17 | |
relation.isAuthorOfPublication | ff868d73-8d06-4d14-8c2a-2d8704871e0b | |
relation.isAuthorOfPublication | 2197b16c-5e35-406d-b33f-ba81fbf26ae2 | |
relation.isAuthorOfPublication.latestForDiscovery | ff868d73-8d06-4d14-8c2a-2d8704871e0b |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_RANZANI_Effect_of_intraoperative_HES_6%_130_0_4_2013.PDF
- Tamanho:
- 415.91 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)